Dr. Eveline Camocardi is a Clinical Research Coordinator II at the Krieger Klein Alzheimer’s Research Center. Her research focuses on intra-individual cognitive variability as a potential low-cost biomarker for the early detection of dementia, examining its relationship with Alzheimer’s disease pathology across diverse cohorts, including individuals with Down syndrome and autosomal dominant Alzheimer’s disease.
Dr. Camocardi earned her medical degree in Brazil and has experience in clinical and occupational medicine, including occupational health, workplace mental health, and supporting the evaluation and accommodation of individuals with disabilities in accordance with regulatory standards. She also has a background in pharmacovigilance and regulatory science, with formal training in clinical drug development from Harvard Medical School.